Grifols SA Financials
| OZTA Stock | EUR 8.47 0.03 0.35% |
Grifols |
Grifols SA Stock Summary
Grifols SA competes with Eli Lilly, AbbVie, Pfizer, and AstraZeneca PLC. Grifols, S.A., a specialty pharmaceutical company, develops, manufactures, and distributes a range of biological medicines on plasma derived proteins worldwide. The company was founded in 1940 and is headquartered in Barcelona, Spain. GRIFOLS SA operates under Drug Manufacturers - Major classification in Germany and is traded on Frankfurt Stock Exchange. It employs 22282 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | ES0171996087 |
| Business Address | Avinguda de la |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Major |
| Benchmark | Dow Jones Industrial |
| Website | www.grifols.com |
| Phone | 34 93 571 02 21 |
| Currency | EUR - Euro |
You should never invest in Grifols SA without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Grifols Stock, because this is throwing your money away. Analyzing the key information contained in Grifols SA's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Grifols SA Key Financial Ratios
There are many critical financial ratios that Grifols SA's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Grifols SA reports annually and quarterly.| Return On Equity | 0.0182 | |||
| Return On Asset | 0.0155 | |||
| Beta | 0.48 | |||
| Z Score | 0.6 |
Grifols Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Grifols SA's current stock value. Our valuation model uses many indicators to compare Grifols SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Grifols SA competition to find correlations between indicators driving Grifols SA's intrinsic value. More Info.Grifols SA is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.85 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Grifols SA is roughly 1.17 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Grifols SA's earnings, one of the primary drivers of an investment's value.Grifols SA Systematic Risk
Grifols SA's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Grifols SA volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourty-five with a total number of output elements of sixteen. The Beta measures systematic risk based on how returns on Grifols SA correlated with the market. If Beta is less than 0 Grifols SA generally moves in the opposite direction as compared to the market. If Grifols SA Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Grifols SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Grifols SA is generally in the same direction as the market. If Beta > 1 Grifols SA moves generally in the same direction as, but more than the movement of the benchmark.
Grifols SA January 31, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Grifols SA help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Grifols SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Grifols SA based on widely used predictive technical indicators. In general, we focus on analyzing Grifols Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Grifols SA's daily price indicators and compare them against related drivers.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 15.6 | |||
| Value At Risk | (4.23) | |||
| Potential Upside | 4.08 |
Complementary Tools for Grifols Stock analysis
When running Grifols SA's price analysis, check to measure Grifols SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grifols SA is operating at the current time. Most of Grifols SA's value examination focuses on studying past and present price action to predict the probability of Grifols SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grifols SA's price. Additionally, you may evaluate how the addition of Grifols SA to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |